{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:09:05Z","timestamp":1774408145941,"version":"3.50.1"},"reference-count":92,"publisher":"American Association for Laboratory Animal Science","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>\n                    Osteoarthritis is the leading cause of disability in the United States and affects approximately half of adults over the age of 65. Many osteoarthritis patients take nonsteroidal anti-inflammatory drugs (NSAIDs) on a long-term basis, often concurrently with proton pump inhibitors (PPIs), such as omeprazole, to prevent gastric ulceration. Mice (\n                    <jats:italic>Mus musculus<\/jats:italic>\n                    ) are a commonly used animal model of osteoarthritis. There are little data regarding long-term administration of NSAIDs or coadministration of PPIs and NSAIDs in mice. This study sought to determine if administration of carprofen, a commonly used veterinary NSAID, has adverse effects when administered for 21 days and if coadministration of omeprazole reduces the incidence of adverse effects. Four groups of C57BL\/6J male (n = 5\/group) and female (n = 5\/group) mice were weighed daily and administered 10 mg\/kg carprofen and 8.2 mg\/kg omeprazole, 10 mg\/kg carprofen, 8.2 mg\/kg omeprazole, or control suspension once daily by oral gavage for 21 days. All mice were euthanized, and complete blood count (CBC), serum chemistry, fecal occult blood, and pyloric histopathology and gastritis scoring were conducted. All animals remained clinically healthy for the duration of the study. White blood cell counts (WBCs) and platelets were significantly lower in the carprofen and omeprazole group. Neutrophil counts were significantly lower in the carprofen and omeprazole and the carprofen groups. Compared with the control group, albumin was significantly higher in the carprofen group. Fecal occult blood tests were negative for all animals. No animals had pyloric mucosal ulceration, and gastritis scores were not significantly different between groups. Body weight significantly decreased for all groups over time, with no significant differences among treatment groups. Carprofen and omeprazole may be safely administered to C57BL\/6J mice for 21 days but may induce significant changes in CBC and serum chemistry.\n                  <\/jats:p>","DOI":"10.30802\/aalas-jaalas-25-069","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T21:04:14Z","timestamp":1763759054000},"page":"1089-1095","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Long-Term Carprofen and Omeprazole Administration in C57BL\/6J Mice"],"prefix":"10.30802","volume":"64","author":[{"given":"Abby","family":"Bernardini","sequence":"first","affiliation":[{"name":"Oklahoma Comparative Medicine Training Program, University of Oklahoma Health Sciences, Oklahoma City, Oklahoma;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianne","family":"Taylor","sequence":"additional","affiliation":[{"name":"Veterinary Pathobiology, Oklahoma State University College of Veterinary Medicine, Stillwater, Oklahoma; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matlock","family":"Jeffries","sequence":"additional","affiliation":[{"name":"Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"12258","reference":[{"issue":"40","key":"bib1","series-title":"MMWR Morb Mortal Wkly Rep.","first-page":"1401","article-title":"Prevalence of arthritis and arthritis-attributable activity limitation\u2014United States, 2016\u20132018","volume":"70","author":"Theis KA","year":"2021","unstructured":"Theis KA, Murphy LB, Guglielmo D, et al. Prevalence of arthritis and arthritis-attributable activity limitation\u2014United States, 2016\u20132018. MMWR Morb Mortal Wkly Rep. 2021;70(40):1401\u20131407."},{"issue":"44","key":"bib2","series-title":"MMWR Morb Mortal Wkly Rep.","first-page":"869","article-title":"Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation\u2014United States, 2010\u20132012","volume":"62","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC). Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation\u2014United States, 2010\u20132012. MMWR Morb Mortal Wkly Rep. 2013;62(44):869\u2013873."},{"key":"bib3","series-title":"Drug Des Devel Ther.","first-page":"2921","article-title":"The development of disease-modifying therapies for osteoarthritis (DMOADs): the evidence to date","volume":"15","author":"Oo WM","year":"2021","unstructured":"Oo WM, Little C, Duong V, Hunter DJ. The development of disease-modifying therapies for osteoarthritis (DMOADs): the evidence to date. Drug Des Devel Ther. 2021;15:2921\u20132945."},{"issue":"1","key":"bib4","series-title":"Arch Bone Jt Surg.","first-page":"11","article-title":"The current role of disease-modifying osteoarthritis drugs","volume":"11","author":"Rodriguez-Merchan EC","year":"2023","unstructured":"Rodriguez-Merchan EC. The current role of disease-modifying osteoarthritis drugs. Arch Bone Jt Surg. 2023;11(1):11\u201322."},{"issue":"5","key":"bib5","series-title":"Int J Med Microbiol.","first-page":"316","article-title":"The mouse gut microbiome revisited: from complex diversity to model ecosystems","volume":"306","author":"Clavel T","year":"2016","unstructured":"Clavel T, Lagkouvardos I, Blaut M, Stecher B. The mouse gut microbiome revisited: from complex diversity to model ecosystems. Int J Med Microbiol. 2016;306(5):316\u2013327."},{"key":"bib6","series-title":"Methods Mol Biol.","first-page":"401","article-title":"Experimental osteoarthritis models in mice","volume":"1194","author":"Lorenz J","year":"2014","unstructured":"Lorenz J, Gr\u00e4ssel S. Experimental osteoarthritis models in mice. Methods Mol Biol. 2014;1194:401\u2013419."},{"issue":"1","key":"bib7","series-title":"Clin Transl Med.","first-page":"36","article-title":"Pros and cons of mouse models for studying osteoarthritis","volume":"7","author":"Bapat S","year":"2018","unstructured":"Bapat S, Hubbard D, Munjal A, Hunter M, Fulzele S. Pros and cons of mouse models for studying osteoarthritis. Clin Transl Med. 2018;7(1):36."},{"key":"bib8","series-title":"Intl J Interferon Cytokine Med Res.","first-page":"19","article-title":"Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects","volume":"3","author":"Pountos I","year":"2011","unstructured":"Pountos I, Georgouli T, Bird H, Giannoudis PV. Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects. Intl J Interferon Cytokine Med Res. 2011;3:19\u201327."},{"issue":"6","key":"bib9","series-title":"Expert Rev Gastroenterol Hepatol.","first-page":"723","article-title":"Management of NSAID-associated peptic ulcer disease","volume":"10","author":"Melcarne L","year":"2016","unstructured":"Melcarne L, Garc\u00eda-Iglesias P, Calvet X. Management of NSAID-associated peptic ulcer disease. Expert Rev Gastroenterol Hepatol. 2016;10(6):723\u2013733."},{"key":"bib10","series-title":"Cochrane Database Syst Rev.","first-page":"CD002296","article-title":"Prevention of NSAID\u2010induced gastroduodenal ulcers","volume":"4","author":"Rostom A","year":"2002","unstructured":"Rostom A, Dube C, Wells GA, et al. Prevention of NSAID\u2010induced gastroduodenal ulcers. Cochrane Database Syst Rev. 2002:4:CD002296."},{"issue":"3","key":"bib11","series-title":"Int J Curr Microbiol App Sci.","first-page":"2475","article-title":"Gastritis and peptic ulcer diseases in dogs: a review","volume":"7","author":"Patel PK","year":"2018","unstructured":"Patel PK, Patel SK, Dixit S, Rathore R. Gastritis and peptic ulcer diseases in dogs: a review. Int J Curr Microbiol App Sci. 2018;7(3):2475\u20132501."},{"issue":"4","key":"bib12","series-title":"J Vet Intern Med.","first-page":"238","article-title":"Gastroduodenal ulceration in dogs: retrospective study of 43 cases and literature review","volume":"3","author":"Stanton ME","year":"1989","unstructured":"Stanton ME, Bright RM. Gastroduodenal ulceration in dogs: retrospective study of 43 cases and literature review. J Vet Intern Med. 1989;3(4):238\u2013244."},{"issue":"4","key":"bib13","series-title":"Intest Res.","first-page":"446","article-title":"Non-steroidal anti-inflammatory drug-induced enteropathy","volume":"15","author":"Shin SJ","year":"2017","unstructured":"Shin SJ, Noh CK, Lim SG, Lee KM, Lee KJ. Non-steroidal anti-inflammatory drug-induced enteropathy. Intest Res. 2017;15(4):446\u2013455."},{"issue":"4","key":"bib14","series-title":"Clin Drug Investig.","first-page":"221","article-title":"Non-steroidal anti-inflammatory drugs and gastroprotection with proton pump inhibitors","volume":"32","author":"Gigante A","year":"2012","unstructured":"Gigante A, Tagarro I. Non-steroidal anti-inflammatory drugs and gastroprotection with proton pump inhibitors. Clin Drug Investig. 2012;32(4):221\u2013233."},{"issue":"suppl 3","key":"bib15","series-title":"Arthritis Res Ther.","first-page":"S5","article-title":"The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage","volume":"15","author":"Scheiman JM","year":"2013","unstructured":"Scheiman JM. The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage. Arthritis Res Ther. 2013;15(suppl 3):S5."},{"issue":"4","key":"bib16","series-title":"Pharmacol Res Perspect.","first-page":"e00817","article-title":"Kidney damage from nonsteroidal anti-inflammatory drugs\u2014myth or truth? Review of selected literature","volume":"9","author":"Dro\u017cd\u017cal S","year":"2021","unstructured":"Dro\u017cd\u017cal S, Lechowicz K, Szostak B, et al. Kidney damage from nonsteroidal anti-inflammatory drugs\u2014myth or truth? Review of selected literature. Pharmacol Res Perspect. 2021;9(4):e00817."},{"issue":"1","key":"bib17","series-title":"Int J Hepatol.","first-page":"5253623","article-title":"Hepatotoxicity of nonsteroidal anti-inflammatory drugs: a systematic review of randomized controlled trials","volume":"2018","author":"Sriuttha P","year":"2018","unstructured":"Sriuttha P, Sirichanchuen B, Permsuwan U. Hepatotoxicity of nonsteroidal anti-inflammatory drugs: a systematic review of randomized controlled trials. Int J Hepatol. 2018;2018(1):5253623."},{"issue":"3","key":"bib18","series-title":"Clin Liver Dis.","first-page":"543","article-title":"NSAID-induced hepatotoxicity","volume":"2","author":"Lewis JH","year":"1998","unstructured":"Lewis JH. NSAID-induced hepatotoxicity. Clin Liver Dis. 1998;2(3):543\u2013561."},{"issue":"3","key":"bib19","series-title":"Neurobiol Dis.","first-page":"449","article-title":"Effects of nonsteroidal anti-inflammatory drugs on amyloid-\u03b2 pathology in mouse skeletal muscle","volume":"39","author":"Beckett TL","year":"2010","unstructured":"Beckett TL, Niedowicz DM, Studzinski CM, et al. Effects of nonsteroidal anti-inflammatory drugs on amyloid-\u03b2 pathology in mouse skeletal muscle. Neurobiol Dis. 2010;39(3):449\u2013456."},{"issue":"7","key":"bib20","series-title":"Brain.","first-page":"2063","article-title":"Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer\u2019s disease model mice","volume":"139","author":"Woodling NS","year":"2016","unstructured":"Woodling NS, Colas D, Wang Q, et al. Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer\u2019s disease model mice. Brain. 2016;139(7):2063\u20132081."},{"key":"bib21","series-title":"Guide for the Care and Use of Laboratory Animals.","year":"2011","unstructured":"Institute for Laboratory Animal Research. Guide for the Care and Use of Laboratory Animals. 8th ed. National Academies Press; 2011."},{"issue":"6","key":"bib22","series-title":"J Am Assoc Lab Anim Sci.","first-page":"545","article-title":"A pharmacokinetic and analgesic efficacy study of carprofen in female CD1 mice","volume":"62","author":"McKenna BA","year":"2023","unstructured":"McKenna BA, Weaver HL, Kim J, Bowman MW, Knych HK, Kendall LV. A pharmacokinetic and analgesic efficacy study of carprofen in female CD1 mice. J Am Assoc Lab Anim Sci. 2023;62(6):545\u2013552."},{"issue":"6","key":"bib23","series-title":"Comp Med.","first-page":"468","article-title":"Clinical management of pain in rodents","volume":"69","author":"Foley PL","year":"2019","unstructured":"Foley PL, Kendall LV, Turner PV. Clinical management of pain in rodents. Comp Med. 2019;69(6):468\u2013489."},{"issue":"2","key":"bib24","series-title":"J Basic Clin Pharm.","first-page":"27","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair AB","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27\u201331."},{"issue":"12","key":"bib25","series-title":"Am J Gastroenterol.","first-page":"2516","article-title":"Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study","volume":"91","author":"Valenzuela JE","year":"1996","unstructured":"Valenzuela JE, Kogut DG, McCullough AJ, et al. Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study. Am J Gastroenterol. 1996;91(12):2516\u20132522."},{"issue":"1","key":"bib26","series-title":"J Am Assoc Lab Anim Sci.","first-page":"75","article-title":"Toxic effects of high-dose meloxicam and carprofen on female CD1 mice","volume":"61","author":"Kendall LV","year":"2022","unstructured":"Kendall LV, Bailey AL, Singh B, McGee W. Toxic effects of high-dose meloxicam and carprofen on female CD1 mice. J Am Assoc Lab Anim Sci. 2022;61(1):75\u201380."},{"key":"bib27","article-title":"C57BL16 Mouse Hematology\u2013North American Colonies, January 2008\u2013December 2011","year":"2012","unstructured":"Charles River Laboratories. C57BL16 Mouse Hematology\u2013North American Colonies, January 2008\u2013December 2011. Technical Sheet. Charles River Laboratories International Inc; 2012."},{"key":"bib28","article-title":"Catalyst one chemistry analyzer resources and manuals","year":"2025","unstructured":"Catalyst one chemistry analyzer resources and manuals. IDEXX. 2025. Accessed June 30, 2025. https:\/\/www.idexx.com\/en\/veterinary\/analyzers\/catalyst-one-chemistry-analyzer\/catalyst-one-resources\/."},{"issue":"18","key":"bib29","series-title":"Arch Intern Med.","first-page":"2119","article-title":"Nonsteroidal anti-inflammatory drugs and neutropenia","volume":"153","author":"Strom BL","year":"1993","unstructured":"Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M, Lundin FE Jr. Nonsteroidal anti-inflammatory drugs and neutropenia. Arch Intern Med. 1993;153(18):2119\u20132124."},{"issue":"8","key":"bib30","series-title":"Clin Drug Investig.","first-page":"559","article-title":"Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole","volume":"30","author":"Gouraud A","year":"2010","unstructured":"Gouraud A, Vochelle V, Descotes J, Vial T. Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole. Clin Drug Investig. 2010;30(8):559\u2013563."},{"issue":"6","key":"bib31","series-title":"Platelets.","first-page":"598","article-title":"Proton pump induced thrombocytopenia: a case report and review of literature","volume":"26","author":"Kallam A","year":"2015","unstructured":"Kallam A, Singla A, Silberstein P. Proton pump induced thrombocytopenia: a case report and review of literature. Platelets. 2015;26(6):598\u2013601."},{"issue":"15","key":"bib32","series-title":"Drug Saf.","first-page":"1243","article-title":"Drug-induced immune thrombocytopenia","volume":"27","author":"Van den Bemt PM","year":"2004","unstructured":"Van den Bemt PM, Meyboom RH, Egberts AC. Drug-induced immune thrombocytopenia. Drug Saf. 2004;27(15):1243\u20131252."},{"issue":"5","key":"bib33","series-title":"J Immunol.","first-page":"2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas J","year":"2004","unstructured":"Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172(5):2731\u20132738."},{"key":"bib34","series-title":"Exotic Animal Laboratory Diagnosis.","first-page":"81","article-title":"Rats and mice","author":"Kusmeirczyk J","year":"2020","unstructured":"Kusmeirczyk J, Kling M, Kier AB, Milligan SM, Heatley JJ. Rats and mice. In: Heatley JJ and Russell KE, editors. Exotic Animal Laboratory Diagnosis. John Wiley & Sons; 2020:81\u2013112."},{"issue":"4","key":"bib35","series-title":"Toxicol Pathol.","first-page":"560","article-title":"Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment","volume":"41","author":"Everds NE","year":"2013","unstructured":"Everds NE, Snyder PW, Bailey KL, et al. Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment. Toxicol Pathol. 2013;41(4):560\u2013614."},{"issue":"1","key":"bib36","series-title":"Toxicol Appl Pharmacol.","first-page":"65","article-title":"A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice","volume":"260","author":"Walker MK","year":"2012","unstructured":"Walker MK, Boberg JR, Walsh MT, et al. A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice. Toxicol Appl Pharmacol. 2012;260(1):65\u201369."},{"issue":"7","key":"bib37","series-title":"Lab Anim (NY).","first-page":"303","article-title":"Evaluation of the neutrophil:lymphocyte ratio as an indicator of chronic distress in the laboratory mouse","volume":"46","author":"Hickman DL","year":"2017","unstructured":"Hickman DL. Evaluation of the neutrophil:lymphocyte ratio as an indicator of chronic distress in the laboratory mouse. Lab Anim (NY). 2017;46(7):303\u2013307."},{"issue":"4","key":"bib38","series-title":"Physiol Behav.","first-page":"387","article-title":"Repetitive orogastric gavage affects the phenotype of diet-induced obese mice","volume":"100","author":"de Meijer VE","year":"2010","unstructured":"de Meijer VE, Le HD, Meisel JA, Puder M. Repetitive orogastric gavage affects the phenotype of diet-induced obese mice. Physiol Behav. 2010;100(4):387\u2013393."},{"issue":"2","key":"bib39","series-title":"Horm Behav.","first-page":"172","article-title":"Chronic stress reduces body fat content in both obesity-prone and obesity-resistant strains of mice","volume":"48","author":"Michel C","year":"2005","unstructured":"Michel C, Duclos M, Cabanac M, Richard D. Chronic stress reduces body fat content in both obesity-prone and obesity-resistant strains of mice. Horm Behav. 2005;48(2):172\u2013179."},{"issue":"4","key":"bib40","series-title":"Endocrinol Metab (Seoul).","first-page":"288","article-title":"Effects of chronic restraint stress on body weight, food intake, and hypothalamic gene expressions in mice","volume":"28","author":"Jeong JY","year":"2013","unstructured":"Jeong JY, Lee DH, Kang SS. Effects of chronic restraint stress on body weight, food intake, and hypothalamic gene expressions in mice. Endocrinol Metab (Seoul). 2013;28(4):288\u2013296."},{"issue":"6","key":"bib41","series-title":"J Am Vet Med Assoc.","first-page":"876","article-title":"Evaluation of adverse effects of long-term orally administered carprofen in dogs","volume":"228","author":"Raekallio MR","year":"2006","unstructured":"Raekallio MR, Hielm-Bj\u00f6rkman AK, Kejonen J, Salonen HM, Sankari SM. Evaluation of adverse effects of long-term orally administered carprofen in dogs. J Am Vet Med Assoc. 2006;228(6):876\u2013880."},{"key":"bib42","series-title":"Compend Cont Educ Pract Vet.","first-page":"940","article-title":"Albumin in health and disease: causes and treatment of hypoalbuminemia","volume":"26","author":"Throop JL","year":"2004","unstructured":"Throop JL, Kerl ME, Cohn LA. Albumin in health and disease: causes and treatment of hypoalbuminemia. Compend Cont Educ Pract Vet. 2004;26:940\u2013948."},{"key":"bib43","series-title":"Front Vet Sci.","first-page":"1430726","article-title":"Subcutaneous and orally self-administered high-dose carprofen shows favorable pharmacokinetic and tolerability profiles in male and female C57BL\/6J mice","volume":"11","author":"Glasenapp A","year":"2024","unstructured":"Glasenapp A, Bankstahl JP, B\u00e4hre H, Glage S, Bankstahl M. Subcutaneous and orally self-administered high-dose carprofen shows favorable pharmacokinetic and tolerability profiles in male and female C57BL\/6J mice. Front Vet Sci. 2024;11:1430726."},{"issue":"5","key":"bib44","series-title":"J Am Assoc Lab Anim Sci.","first-page":"553","article-title":"Aqueous stability and oral pharmacokinetics of meloxicam and carprofen in male C57BL\/6 mice","volume":"52","author":"Ingrao JC","year":"2013","unstructured":"Ingrao JC, Johnson R, Tor E, Gu Y, Litman M, Turner PV. Aqueous stability and oral pharmacokinetics of meloxicam and carprofen in male C57BL\/6 mice. J Am Assoc Lab Anim Sci. 2013;52(5):553\u2013559."},{"issue":"2","key":"bib45","series-title":"J Am Assoc Lab Anim Sci.","first-page":"204","article-title":"Efficacy and effects of high-dose carprofen after plantar incision in C57BL\/6J mice","volume":"64","author":"Cotton RM","year":"2025","unstructured":"Cotton RM, Casey KM, Alamaw ED, et al. Efficacy and effects of high-dose carprofen after plantar incision in C57BL\/6J mice. J Am Assoc Lab Anim Sci. 2025;64(2):204\u2013211."},{"issue":"2","key":"bib46","series-title":"Comp Med.","first-page":"105","article-title":"Carprofen attenuates postoperative mechanical and thermal hypersensitivity after plantar incision in immunodeficient NSG mice","volume":"74","author":"Alamaw ED","year":"2024","unstructured":"Alamaw ED, Casey KM, Tien K, et al. Carprofen attenuates postoperative mechanical and thermal hypersensitivity after plantar incision in immunodeficient NSG mice. Comp Med. 2024;74(2):105\u2013114."},{"issue":"40","key":"bib1","series-title":"MMWR Morb Mortal Wkly Rep.","first-page":"1401","article-title":"Prevalence of arthritis and arthritis-attributable activity limitation\u2014United States, 2016\u20132018","volume":"70","author":"Theis KA","year":"2021","unstructured":"Theis KA, Murphy LB, Guglielmo D, et al. Prevalence of arthritis and arthritis-attributable activity limitation\u2014United States, 2016\u20132018. MMWR Morb Mortal Wkly Rep. 2021;70(40):1401\u20131407."},{"issue":"44","key":"bib2","series-title":"MMWR Morb Mortal Wkly Rep.","first-page":"869","article-title":"Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation\u2014United States, 2010\u20132012","volume":"62","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC). Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation\u2014United States, 2010\u20132012. MMWR Morb Mortal Wkly Rep. 2013;62(44):869\u2013873."},{"key":"bib3","series-title":"Drug Des Devel Ther.","first-page":"2921","article-title":"The development of disease-modifying therapies for osteoarthritis (DMOADs): the evidence to date","volume":"15","author":"Oo WM","year":"2021","unstructured":"Oo WM, Little C, Duong V, Hunter DJ. The development of disease-modifying therapies for osteoarthritis (DMOADs): the evidence to date. Drug Des Devel Ther. 2021;15:2921\u20132945."},{"issue":"1","key":"bib4","series-title":"Arch Bone Jt Surg.","first-page":"11","article-title":"The current role of disease-modifying osteoarthritis drugs","volume":"11","author":"Rodriguez-Merchan EC","year":"2023","unstructured":"Rodriguez-Merchan EC. The current role of disease-modifying osteoarthritis drugs. Arch Bone Jt Surg. 2023;11(1):11\u201322."},{"issue":"5","key":"bib5","series-title":"Int J Med Microbiol.","first-page":"316","article-title":"The mouse gut microbiome revisited: from complex diversity to model ecosystems","volume":"306","author":"Clavel T","year":"2016","unstructured":"Clavel T, Lagkouvardos I, Blaut M, Stecher B. The mouse gut microbiome revisited: from complex diversity to model ecosystems. Int J Med Microbiol. 2016;306(5):316\u2013327."},{"key":"bib6","series-title":"Methods Mol Biol.","first-page":"401","article-title":"Experimental osteoarthritis models in mice","volume":"1194","author":"Lorenz J","year":"2014","unstructured":"Lorenz J, Gr\u00e4ssel S. Experimental osteoarthritis models in mice. Methods Mol Biol. 2014;1194:401\u2013419."},{"issue":"1","key":"bib7","series-title":"Clin Transl Med.","first-page":"36","article-title":"Pros and cons of mouse models for studying osteoarthritis","volume":"7","author":"Bapat S","year":"2018","unstructured":"Bapat S, Hubbard D, Munjal A, Hunter M, Fulzele S. Pros and cons of mouse models for studying osteoarthritis. Clin Transl Med. 2018;7(1):36."},{"key":"bib8","series-title":"Intl J Interferon Cytokine Med Res.","first-page":"19","article-title":"Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects","volume":"3","author":"Pountos I","year":"2011","unstructured":"Pountos I, Georgouli T, Bird H, Giannoudis PV. Nonsteroidal anti-inflammatory drugs: prostaglandins, indications, and side effects. Intl J Interferon Cytokine Med Res. 2011;3:19\u201327."},{"issue":"6","key":"bib9","series-title":"Expert Rev Gastroenterol Hepatol.","first-page":"723","article-title":"Management of NSAID-associated peptic ulcer disease","volume":"10","author":"Melcarne L","year":"2016","unstructured":"Melcarne L, Garc\u00eda-Iglesias P, Calvet X. Management of NSAID-associated peptic ulcer disease. Expert Rev Gastroenterol Hepatol. 2016;10(6):723\u2013733."},{"key":"bib10","series-title":"Cochrane Database Syst Rev.","first-page":"CD002296","article-title":"Prevention of NSAID\u2010induced gastroduodenal ulcers","volume":"4","author":"Rostom A","year":"2002","unstructured":"Rostom A, Dube C, Wells GA, et al. Prevention of NSAID\u2010induced gastroduodenal ulcers. Cochrane Database Syst Rev. 2002:4:CD002296."},{"issue":"3","key":"bib11","series-title":"Int J Curr Microbiol App Sci.","first-page":"2475","article-title":"Gastritis and peptic ulcer diseases in dogs: a review","volume":"7","author":"Patel PK","year":"2018","unstructured":"Patel PK, Patel SK, Dixit S, Rathore R. Gastritis and peptic ulcer diseases in dogs: a review. Int J Curr Microbiol App Sci. 2018;7(3):2475\u20132501."},{"issue":"4","key":"bib12","series-title":"J Vet Intern Med.","first-page":"238","article-title":"Gastroduodenal ulceration in dogs: retrospective study of 43 cases and literature review","volume":"3","author":"Stanton ME","year":"1989","unstructured":"Stanton ME, Bright RM. Gastroduodenal ulceration in dogs: retrospective study of 43 cases and literature review. J Vet Intern Med. 1989;3(4):238\u2013244."},{"issue":"4","key":"bib13","series-title":"Intest Res.","first-page":"446","article-title":"Non-steroidal anti-inflammatory drug-induced enteropathy","volume":"15","author":"Shin SJ","year":"2017","unstructured":"Shin SJ, Noh CK, Lim SG, Lee KM, Lee KJ. Non-steroidal anti-inflammatory drug-induced enteropathy. Intest Res. 2017;15(4):446\u2013455."},{"issue":"4","key":"bib14","series-title":"Clin Drug Investig.","first-page":"221","article-title":"Non-steroidal anti-inflammatory drugs and gastroprotection with proton pump inhibitors","volume":"32","author":"Gigante A","year":"2012","unstructured":"Gigante A, Tagarro I. Non-steroidal anti-inflammatory drugs and gastroprotection with proton pump inhibitors. Clin Drug Investig. 2012;32(4):221\u2013233."},{"issue":"suppl 3","key":"bib15","series-title":"Arthritis Res Ther.","first-page":"S5","article-title":"The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage","volume":"15","author":"Scheiman JM","year":"2013","unstructured":"Scheiman JM. The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage. Arthritis Res Ther. 2013;15(suppl 3):S5."},{"issue":"4","key":"bib16","series-title":"Pharmacol Res Perspect.","first-page":"e00817","article-title":"Kidney damage from nonsteroidal anti-inflammatory drugs\u2014myth or truth? Review of selected literature","volume":"9","author":"Dro\u017cd\u017cal S","year":"2021","unstructured":"Dro\u017cd\u017cal S, Lechowicz K, Szostak B, et al. Kidney damage from nonsteroidal anti-inflammatory drugs\u2014myth or truth? Review of selected literature. Pharmacol Res Perspect. 2021;9(4):e00817."},{"issue":"1","key":"bib17","series-title":"Int J Hepatol.","first-page":"5253623","article-title":"Hepatotoxicity of nonsteroidal anti-inflammatory drugs: a systematic review of randomized controlled trials","volume":"2018","author":"Sriuttha P","year":"2018","unstructured":"Sriuttha P, Sirichanchuen B, Permsuwan U. Hepatotoxicity of nonsteroidal anti-inflammatory drugs: a systematic review of randomized controlled trials. Int J Hepatol. 2018;2018(1):5253623."},{"issue":"3","key":"bib18","series-title":"Clin Liver Dis.","first-page":"543","article-title":"NSAID-induced hepatotoxicity","volume":"2","author":"Lewis JH","year":"1998","unstructured":"Lewis JH. NSAID-induced hepatotoxicity. Clin Liver Dis. 1998;2(3):543\u2013561."},{"issue":"3","key":"bib19","series-title":"Neurobiol Dis.","first-page":"449","article-title":"Effects of nonsteroidal anti-inflammatory drugs on amyloid-\u03b2 pathology in mouse skeletal muscle","volume":"39","author":"Beckett TL","year":"2010","unstructured":"Beckett TL, Niedowicz DM, Studzinski CM, et al. Effects of nonsteroidal anti-inflammatory drugs on amyloid-\u03b2 pathology in mouse skeletal muscle. Neurobiol Dis. 2010;39(3):449\u2013456."},{"issue":"7","key":"bib20","series-title":"Brain.","first-page":"2063","article-title":"Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer\u2019s disease model mice","volume":"139","author":"Woodling NS","year":"2016","unstructured":"Woodling NS, Colas D, Wang Q, et al. Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer\u2019s disease model mice. Brain. 2016;139(7):2063\u20132081."},{"key":"bib21","series-title":"Guide for the Care and Use of Laboratory Animals.","year":"2011","unstructured":"Institute for Laboratory Animal Research. Guide for the Care and Use of Laboratory Animals. 8th ed. National Academies Press; 2011."},{"issue":"6","key":"bib22","series-title":"J Am Assoc Lab Anim Sci.","first-page":"545","article-title":"A pharmacokinetic and analgesic efficacy study of carprofen in female CD1 mice","volume":"62","author":"McKenna BA","year":"2023","unstructured":"McKenna BA, Weaver HL, Kim J, Bowman MW, Knych HK, Kendall LV. A pharmacokinetic and analgesic efficacy study of carprofen in female CD1 mice. J Am Assoc Lab Anim Sci. 2023;62(6):545\u2013552."},{"issue":"6","key":"bib23","series-title":"Comp Med.","first-page":"468","article-title":"Clinical management of pain in rodents","volume":"69","author":"Foley PL","year":"2019","unstructured":"Foley PL, Kendall LV, Turner PV. Clinical management of pain in rodents. Comp Med. 2019;69(6):468\u2013489."},{"issue":"2","key":"bib24","series-title":"J Basic Clin Pharm.","first-page":"27","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair AB","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27\u201331."},{"issue":"12","key":"bib25","series-title":"Am J Gastroenterol.","first-page":"2516","article-title":"Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study","volume":"91","author":"Valenzuela JE","year":"1996","unstructured":"Valenzuela JE, Kogut DG, McCullough AJ, et al. Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study. Am J Gastroenterol. 1996;91(12):2516\u20132522."},{"issue":"1","key":"bib26","series-title":"J Am Assoc Lab Anim Sci.","first-page":"75","article-title":"Toxic effects of high-dose meloxicam and carprofen on female CD1 mice","volume":"61","author":"Kendall LV","year":"2022","unstructured":"Kendall LV, Bailey AL, Singh B, McGee W. Toxic effects of high-dose meloxicam and carprofen on female CD1 mice. J Am Assoc Lab Anim Sci. 2022;61(1):75\u201380."},{"key":"bib27","article-title":"C57BL16 Mouse Hematology\u2013North American Colonies, January 2008\u2013December 2011","year":"2012","unstructured":"Charles River Laboratories. C57BL16 Mouse Hematology\u2013North American Colonies, January 2008\u2013December 2011. Technical Sheet. Charles River Laboratories International Inc; 2012."},{"key":"bib28","article-title":"Catalyst one chemistry analyzer resources and manuals","year":"2025","unstructured":"Catalyst one chemistry analyzer resources and manuals. IDEXX. 2025. Accessed June 30, 2025. https:\/\/www.idexx.com\/en\/veterinary\/analyzers\/catalyst-one-chemistry-analyzer\/catalyst-one-resources\/."},{"issue":"18","key":"bib29","series-title":"Arch Intern Med.","first-page":"2119","article-title":"Nonsteroidal anti-inflammatory drugs and neutropenia","volume":"153","author":"Strom BL","year":"1993","unstructured":"Strom BL, Carson JL, Schinnar R, Snyder ES, Shaw M, Lundin FE Jr. Nonsteroidal anti-inflammatory drugs and neutropenia. Arch Intern Med. 1993;153(18):2119\u20132124."},{"issue":"8","key":"bib30","series-title":"Clin Drug Investig.","first-page":"559","article-title":"Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole","volume":"30","author":"Gouraud A","year":"2010","unstructured":"Gouraud A, Vochelle V, Descotes J, Vial T. Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole. Clin Drug Investig. 2010;30(8):559\u2013563."},{"issue":"6","key":"bib31","series-title":"Platelets.","first-page":"598","article-title":"Proton pump induced thrombocytopenia: a case report and review of literature","volume":"26","author":"Kallam A","year":"2015","unstructured":"Kallam A, Singla A, Silberstein P. Proton pump induced thrombocytopenia: a case report and review of literature. Platelets. 2015;26(6):598\u2013601."},{"issue":"15","key":"bib32","series-title":"Drug Saf.","first-page":"1243","article-title":"Drug-induced immune thrombocytopenia","volume":"27","author":"Van den Bemt PM","year":"2004","unstructured":"Van den Bemt PM, Meyboom RH, Egberts AC. Drug-induced immune thrombocytopenia. Drug Saf. 2004;27(15):1243\u20131252."},{"issue":"5","key":"bib33","series-title":"J Immunol.","first-page":"2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas J","year":"2004","unstructured":"Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172(5):2731\u20132738."},{"key":"bib34","series-title":"Exotic Animal Laboratory Diagnosis.","first-page":"81","article-title":"Rats and mice","author":"Kusmeirczyk J","year":"2020","unstructured":"Kusmeirczyk J, Kling M, Kier AB, Milligan SM, Heatley JJ. Rats and mice. In: Heatley JJ and Russell KE, editors. Exotic Animal Laboratory Diagnosis. John Wiley & Sons; 2020:81\u2013112."},{"issue":"4","key":"bib35","series-title":"Toxicol Pathol.","first-page":"560","article-title":"Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment","volume":"41","author":"Everds NE","year":"2013","unstructured":"Everds NE, Snyder PW, Bailey KL, et al. Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment. Toxicol Pathol. 2013;41(4):560\u2013614."},{"issue":"1","key":"bib36","series-title":"Toxicol Appl Pharmacol.","first-page":"65","article-title":"A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice","volume":"260","author":"Walker MK","year":"2012","unstructured":"Walker MK, Boberg JR, Walsh MT, et al. A less stressful alternative to oral gavage for pharmacological and toxicological studies in mice. Toxicol Appl Pharmacol. 2012;260(1):65\u201369."},{"issue":"7","key":"bib37","series-title":"Lab Anim (NY).","first-page":"303","article-title":"Evaluation of the neutrophil:lymphocyte ratio as an indicator of chronic distress in the laboratory mouse","volume":"46","author":"Hickman DL","year":"2017","unstructured":"Hickman DL. Evaluation of the neutrophil:lymphocyte ratio as an indicator of chronic distress in the laboratory mouse. Lab Anim (NY). 2017;46(7):303\u2013307."},{"issue":"4","key":"bib38","series-title":"Physiol Behav.","first-page":"387","article-title":"Repetitive orogastric gavage affects the phenotype of diet-induced obese mice","volume":"100","author":"de Meijer VE","year":"2010","unstructured":"de Meijer VE, Le HD, Meisel JA, Puder M. Repetitive orogastric gavage affects the phenotype of diet-induced obese mice. Physiol Behav. 2010;100(4):387\u2013393."},{"issue":"2","key":"bib39","series-title":"Horm Behav.","first-page":"172","article-title":"Chronic stress reduces body fat content in both obesity-prone and obesity-resistant strains of mice","volume":"48","author":"Michel C","year":"2005","unstructured":"Michel C, Duclos M, Cabanac M, Richard D. Chronic stress reduces body fat content in both obesity-prone and obesity-resistant strains of mice. Horm Behav. 2005;48(2):172\u2013179."},{"issue":"4","key":"bib40","series-title":"Endocrinol Metab (Seoul).","first-page":"288","article-title":"Effects of chronic restraint stress on body weight, food intake, and hypothalamic gene expressions in mice","volume":"28","author":"Jeong JY","year":"2013","unstructured":"Jeong JY, Lee DH, Kang SS. Effects of chronic restraint stress on body weight, food intake, and hypothalamic gene expressions in mice. Endocrinol Metab (Seoul). 2013;28(4):288\u2013296."},{"issue":"6","key":"bib41","series-title":"J Am Vet Med Assoc.","first-page":"876","article-title":"Evaluation of adverse effects of long-term orally administered carprofen in dogs","volume":"228","author":"Raekallio MR","year":"2006","unstructured":"Raekallio MR, Hielm-Bj\u00f6rkman AK, Kejonen J, Salonen HM, Sankari SM. Evaluation of adverse effects of long-term orally administered carprofen in dogs. J Am Vet Med Assoc. 2006;228(6):876\u2013880."},{"key":"bib42","series-title":"Compend Cont Educ Pract Vet.","first-page":"940","article-title":"Albumin in health and disease: causes and treatment of hypoalbuminemia","volume":"26","author":"Throop JL","year":"2004","unstructured":"Throop JL, Kerl ME, Cohn LA. Albumin in health and disease: causes and treatment of hypoalbuminemia. Compend Cont Educ Pract Vet. 2004;26:940\u2013948."},{"key":"bib43","series-title":"Front Vet Sci.","first-page":"1430726","article-title":"Subcutaneous and orally self-administered high-dose carprofen shows favorable pharmacokinetic and tolerability profiles in male and female C57BL\/6J mice","volume":"11","author":"Glasenapp A","year":"2024","unstructured":"Glasenapp A, Bankstahl JP, B\u00e4hre H, Glage S, Bankstahl M. Subcutaneous and orally self-administered high-dose carprofen shows favorable pharmacokinetic and tolerability profiles in male and female C57BL\/6J mice. Front Vet Sci. 2024;11:1430726."},{"issue":"5","key":"bib44","series-title":"J Am Assoc Lab Anim Sci.","first-page":"553","article-title":"Aqueous stability and oral pharmacokinetics of meloxicam and carprofen in male C57BL\/6 mice","volume":"52","author":"Ingrao JC","year":"2013","unstructured":"Ingrao JC, Johnson R, Tor E, Gu Y, Litman M, Turner PV. Aqueous stability and oral pharmacokinetics of meloxicam and carprofen in male C57BL\/6 mice. J Am Assoc Lab Anim Sci. 2013;52(5):553\u2013559."},{"issue":"2","key":"bib45","series-title":"J Am Assoc Lab Anim Sci.","first-page":"204","article-title":"Efficacy and effects of high-dose carprofen after plantar incision in C57BL\/6J mice","volume":"64","author":"Cotton RM","year":"2025","unstructured":"Cotton RM, Casey KM, Alamaw ED, et al. Efficacy and effects of high-dose carprofen after plantar incision in C57BL\/6J mice. J Am Assoc Lab Anim Sci. 2025;64(2):204\u2013211."},{"issue":"2","key":"bib46","series-title":"Comp Med.","first-page":"105","article-title":"Carprofen attenuates postoperative mechanical and thermal hypersensitivity after plantar incision in immunodeficient NSG mice","volume":"74","author":"Alamaw ED","year":"2024","unstructured":"Alamaw ED, Casey KM, Tien K, et al. Carprofen attenuates postoperative mechanical and thermal hypersensitivity after plantar incision in immunodeficient NSG mice. Comp Med. 2024;74(2):105\u2013114."}],"container-title":["Journal of the American Association for Laboratory Animal Science"],"original-title":[],"link":[{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010024\/64\/6\/article-p1089.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010024\/64\/6\/article-p1089.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010024\/64\/6\/article-p1089.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T02:40:25Z","timestamp":1774406425000},"score":1,"resource":{"primary":{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010024\/64\/6\/article-p1089.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":92,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.30802\/aalas-jaalas-25-069","relation":{},"ISSN":["1559-6109"],"issn-type":[{"value":"1559-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}